Agilent Technologies (A)
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$150.86+0.59%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · A
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -1.8% |
| Our one-year growth estimate | diamond | 7.2% |
Growth built into the price is above our model estimate.
The price assumes 9.0 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Model as of 2026-09-04 · Compared with 32 industry peers · Company calendar date is not available
A — capital allocation — Creation of a Direct Financial Obligation or an Obligation under an Off-Balan…
Dated 2026-06-25
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth above under
Why it matters: Lower revenue guidance shows weaker demand. This could hurt investor confidence.
Worry ifQ4 revenue guidance below $1.98 billion, indicating a slowdown in growth.
Less concerning ifQ4 revenue guidance meets or exceeds $1.98 billion, showing continued strength.
Why it matters: Guidance will show if Agilent can keep growing despite market changes.
Supportive ifQ2 2026 revenue guidance shows growth expectations above 10% year over year.
Worry ifQ2 2026 revenue guidance indicates growth below 5% year over year.
Why it matters: A new CFO can change financial plans and boost investor trust. This change is important for finances.
Watch forThey announced a permanent CFO who has the right experience.
Also watch forThere is no announcement or the CFO is still interim.
Why it matters: Updates on the buyback program can show confidence in cash flow and spending plans.
Supportive ifNews about finished share buybacks or progress on the buyback program.
Worry ifNo updates or delays in executing the share buyback plan.
Why it matters: A new CFO can impact financial strategy and investor confidence. This is key for growth.
Watch forA press release announcing the appointment of a new CFO before July 31, 2025.
Also watch forNo announcement of a new CFO by the end of July 2025.
Why it matters: This EPS number shows strong operations and better profit margins.
Supportive ifNon-GAAP EPS was $1.71 or more. This shows good cost control.
Worry ifNon-GAAP EPS was below $1.71. This means margin pressures may exist.
Why it matters: A cut in EPS guidance may show operational problems. This can change how the market sees the company.
Worry ifNon-GAAP EPS guidance below $1.71 shows possible profit issues.
Less concerning ifNon-GAAP EPS guidance at or above $1.71 shows strong earnings.
Why it matters: Slower growth in this key area could hurt the company's overall performance.
Worry ifLife Sciences and Diagnostics revenue grew less than 10% from last year. This shows market weakness.
Less concerning ifGrowth in Life Sciences and Diagnostics remains above 10%, showing strong demand.
Why it matters: Earnings results will show how Agilent is doing and its place in the market. It will reflect management's guidance.
Watch forEarnings report shows revenue and EPS in line with or above guidance.
Also watch forEarnings report shows revenue and EPS below guidance.
Why it matters: Progress on this initiative is crucial for Agilent's growth. Delays could signal deeper issues.
Worry ifManagement says they are improving operations. They see clear results from these changes.
Less concerning ifManagement says the changes in operations are late and lacks clear plans to fix it.
Why it matters: Better margins mean the company controls costs well. This shows they run operations efficiently.
Supportive ifNon-GAAP operating margin grew by over 130 basis points.
Worry ifNon-GAAP operating margin grew by less than 130 basis points.
Why it matters: Revenue growth is a key priority. Strong growth signals effective execution of Agilent's strategy.
Supportive ifRevenue growth for fiscal year 2026 exceeds the guidance of $7.39-$7.49 billion.
Worry ifRevenue growth falls short of the guidance range.
Why it matters: This shows strong profits and good cost control. It shows Agilent can meet its earnings goals.
Supportive ifNon-GAAP EPS for FY 2026 reported at or above $6.00.
Worry ifNon-GAAP EPS for FY 2026 reported below $6.00.
Why it matters: The new structure aims to enhance growth and customer focus. Its effectiveness is crucial.
Supportive ifCustomers or analysts give good feedback on the new structure after Q1 2025.
Worry ifBad feedback or no growth after Q1 2025 results.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$90 on $10,000 · ±0.9% | How much price usually moves either way. |
| Bad day | $284 loss on $10,000 · 2.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,975 loss on $10,000 · 29.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.